Network origin in Irene Chong first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Cambridge Science Corp.
 Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA.
3
| Private Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Irene Chong via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director of Finance/CFO | |
| U.B. Vehicle Leasing, Inc. | President | ||
Whirlpool Financial Corp.
 Whirlpool Financial Corp. Investment ManagersFinance Part of Whirlpool Corp., Whirlpool Financial Corp. provides financial advisory services. | Investment Managers | Director of Finance/CFO | |
| Syracuse University | College/University | Masters Business Admin | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
| HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member | |
| NOVIMMUNE SA | Medical/Nursing Services | Director of Finance/CFO | |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Internet Software/Services | Director/Board Member | |
| Vivtex Corp. | Director/Board Member | ||
| Hamlin Scientific Corp. | Director of Finance/CFO | ||
KYTTARO Ltd.
 KYTTARO Ltd. BiotechnologyHealth Technology Kyttaro Ltd. develops monoclonal antibodies for potential treatment of atherosclerotic cardiovascular diseases. The company is based in Oxford, UK. The British company was founded in 2021. The CEO is Douglas Eby. | Biotechnology | Chief Executive Officer | |
| SOLE REALISATION COMPANY PLC | Investment Managers | Director/Board Member |
Statistics
International
| United States | 10 |
| United Kingdom | 5 |
| Switzerland | 2 |
| Japan | 2 |
Sectoral
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Operational
| Director/Board Member | 9 |
| Director of Finance/CFO | 8 |
| Chief Executive Officer | 3 |
| President | 2 |
| Independent Dir/Board Member | 2 |
Most connected contacts
| Insiders | |
|---|---|
| James Francis Winschel | 14 |
| Douglas Eby | 2 |
| Gary Steinberg | 2 |
- Stock Market
- Insiders
- Irene Chong
- Company connections
